With the tremendous expense of bringing new drugs to market, a focus on improving the outcome of first-stage research is critical.  Recent evidence confirms the need for innovative screening systems utilizing assay design on three-dimensional tissue models and phenotypic models.  This functional analysis will allow for more accurate biological response.  Cambridge Healthtech Institute is pleased to introduce FAST: Functional Analysis & Screening Technologies Congress to bring together drug research and development teams for practical discussion, solutions and case studies for refining these first-stage drug discovery methods.

For further information click here